Positive Predictive Value of Cirrhosis and Chronic Pancreatitis Diagnoses in Individuals with Alcohol Use Disorder: A Single-Center Study.

Alcohol use disorder Chronic pancreatitis Cirrhosis ICD International Classification of Diseases

Journal

Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782

Informations de publication

Date de publication:
29 Nov 2023
Historique:
received: 18 03 2023
accepted: 06 11 2023
medline: 29 11 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: aheadofprint

Résumé

Although accuracy of diagnosis codes for cirrhosis and chronic pancreatitis (CP) has been evaluated in multiple studies, none have focused on patients with alcohol use disorders (AUD). We evaluated the positive predictive value (PPV) for a verified diagnosis of cirrhosis and CP in AUD patients treated at a tertiary care center. We performed a detailed review of electronic health records for AUD patients assigned ICD-9 or 10 codes for alcoholic cirrhosis (ALC) (n = 199), CP (n = 200), or both (n = 200). We calculated PPV for a verified diagnosis of cirrhosis and CP and performed multivariable regression analysis to assess the impact of relevant factors on PPV for a verified diagnosis. PPV of cirrhosis was 81.2% (95% CI 77.0 to 84.9%) which increased to 87.5% (95% CI 83.8 to 90.6%) if the definition was relaxed to include alcohol-related hepatitis. PPV of CP was 54.5% (95% CI 49.5 to 59.5%) which increased to 78% (95% CI 73.6 to 82.0%) when recurrent acute pancreatitis was included in the definition. In multivariable analyses, the odds of a verified diagnosis were significantly higher in individuals aged 65+ years for both cirrhosis (OR 12.23, 95% CI 2.19 to 68.42) and CP (OR 8.84, 95% CI 2.7 to 28.93) and in ever smokers for CP (OR 1.95, 95% CI 1.05 to 3.65). PPV for diagnosis codes in AUD patients is high for a verified diagnosis of cirrhosis but only modest for CP. While administrative datasets can provide reliable information for cirrhosis, future studies should focus on ways to boost the diagnostic validity of administrative datasets for CP.

Sections du résumé

BACKGROUND BACKGROUND
Although accuracy of diagnosis codes for cirrhosis and chronic pancreatitis (CP) has been evaluated in multiple studies, none have focused on patients with alcohol use disorders (AUD). We evaluated the positive predictive value (PPV) for a verified diagnosis of cirrhosis and CP in AUD patients treated at a tertiary care center.
METHODS METHODS
We performed a detailed review of electronic health records for AUD patients assigned ICD-9 or 10 codes for alcoholic cirrhosis (ALC) (n = 199), CP (n = 200), or both (n = 200). We calculated PPV for a verified diagnosis of cirrhosis and CP and performed multivariable regression analysis to assess the impact of relevant factors on PPV for a verified diagnosis.
RESULTS RESULTS
PPV of cirrhosis was 81.2% (95% CI 77.0 to 84.9%) which increased to 87.5% (95% CI 83.8 to 90.6%) if the definition was relaxed to include alcohol-related hepatitis. PPV of CP was 54.5% (95% CI 49.5 to 59.5%) which increased to 78% (95% CI 73.6 to 82.0%) when recurrent acute pancreatitis was included in the definition. In multivariable analyses, the odds of a verified diagnosis were significantly higher in individuals aged 65+ years for both cirrhosis (OR 12.23, 95% CI 2.19 to 68.42) and CP (OR 8.84, 95% CI 2.7 to 28.93) and in ever smokers for CP (OR 1.95, 95% CI 1.05 to 3.65).
CONCLUSION CONCLUSIONS
PPV for diagnosis codes in AUD patients is high for a verified diagnosis of cirrhosis but only modest for CP. While administrative datasets can provide reliable information for cirrhosis, future studies should focus on ways to boost the diagnostic validity of administrative datasets for CP.

Identifiants

pubmed: 38019381
doi: 10.1007/s10620-023-08183-x
pii: 10.1007/s10620-023-08183-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Roerecke M, Vafaei A, Hasan OSM et al. Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2019;114:1574–1586.
doi: 10.14309/ajg.0000000000000340 pubmed: 31464740 pmcid: 6776700
Samokhvalov AV, Rehm J, Roerecke M. Alcohol Consumption as a Risk Factor for Acute and Chronic Pancreatitis: A Systematic Review and a Series of Meta-analyses. EBioMedicine 2015;2:1996–2002.
doi: 10.1016/j.ebiom.2015.11.023 pubmed: 26844279 pmcid: 4703772
Seitz HK, Bataller R, Cortez-Pinto H et al. Alcoholic liver disease. Nat Rev Dis Primers 2018;4:16.
doi: 10.1038/s41572-018-0014-7 pubmed: 30115921
Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013;144:1252–1261.
doi: 10.1053/j.gastro.2013.01.068 pubmed: 23622135
Global status report on alcohol and health 2018. World Health Organization, Geneva, 2018:75.
O’Malley KJ, Cook KF, Price MD, Wildes KR, Hurdle JF, Ashton CM. Measuring diagnoses: ICD code accuracy. Health Serv Res 2005;40:1620–1639.
doi: 10.1111/j.1475-6773.2005.00444.x pubmed: 16178999 pmcid: 1361216
Dahiya M, Eboreime E, Hyde A et al. International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases. Dig Dis Sci 2022;67:2107–2122.
doi: 10.1007/s10620-021-07076-1 pubmed: 34091800
Burkholder DA, Moran IJ, DiBattista JV, Lok AS, Parikh ND, Chen VL. Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications. Dig Dis Sci 2022;67:3623–3632.
doi: 10.1007/s10620-021-07282-x pubmed: 34674069
Xiao AY, Tan ML, Plana MN, Yadav D, Zamora J, Petrov MS. The Use of International Classification of Diseases Codes to Identify Patients with Pancreatitis: A Systematic Review and Meta-analysis of Diagnostic Accuracy Studies. Clin Transl Gastroenterol 2018;9:191.
doi: 10.1038/s41424-018-0060-1 pubmed: 30287807 pmcid: 6172207
Banks PA, Bollen TL, Dervenis C et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013;62:102–111.
doi: 10.1136/gutjnl-2012-302779 pubmed: 23100216
Whitcomb DC, Shimosegawa T, Chari ST et al. International consensus statements on early chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with The International Association of Pancreatology, American Pancreatic Association, Japan Pancreas Society, PancreasFest Working Group and European Pancreatic Club. Pancreatology 2018;18:516–527.
doi: 10.1016/j.pan.2018.05.008 pubmed: 29793839
Vanga RR, Tansel A, Sidiq S, El-Serag HB, Othman MO. Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2018;16:1220–1228.
doi: 10.1016/j.cgh.2018.01.027 pubmed: 29374614 pmcid: 6402774
Conwell DL, Lee LS, Yadav D et al. American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines. Pancreas 2014;43:1143–1162.
doi: 10.1097/MPA.0000000000000237 pubmed: 25333398 pmcid: 5434978
Stevens T, Lopez R, Adler DG et al. Multicenter comparison of the interobserver agreement of standard EUS scoring and Rosemont classification scoring for diagnosis of chronic pancreatitis. Gastrointest Endosc 2010;71:519–526.
doi: 10.1016/j.gie.2009.10.043 pubmed: 20189510
Mel Wilcox C, Gress T, Boermeester M et al. International consensus guidelines on the role of diagnostic endoscopic ultrasound in the management of chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club. Pancreatology 2020;20:822–827.
doi: 10.1016/j.pan.2020.05.025 pubmed: 32631791
Sheel ARG, Baron RD, Sarantitis I et al. The diagnostic value of Rosemont and Japanese diagnostic criteria for “indeterminate”, “suggestive”, “possible” and “early” chronic pancreatitis. Pancreatology 2018;18:774–784.
doi: 10.1016/j.pan.2018.08.002 pubmed: 30119992

Auteurs

Yujie Sun (Y)

Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Michael Lu (M)

Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Robert Feldman (R)

Center for Research on Health Care Data Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Melissa Saul (M)

Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Andrew Althouse (A)

Center for Research on Health Care Data Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Gavin Arteel (G)

Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Medical Center, 200 Lothrop Street, M2, C-wing, Pittsburgh, PA, 15213, USA.

Dhiraj Yadav (D)

Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Medical Center, 200 Lothrop Street, M2, C-wing, Pittsburgh, PA, 15213, USA. yadavd@upmc.edu.

Classifications MeSH